Dicerna Pharmaceuticals Inc. (DRNA) Declined -14.51% or -1.82 To Price $10.72 On Tuesday


Dicerna Pharmaceuticals Inc. (DRNA) declined -14.51% or -1.82 to $10.72. It is near 694976 shares traded, which is 164.22% compare to the average total volume 423211. The market cap of DRNA is $554.94 million. The year to date change is 33.97%. The 52 week price range is from $2.52 to $15.0. Price of DRNA have changed -9.59% during last week. It have changed 6.09% over last month, 70.61% over last 3 months, N/A N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 10.85. It is 1.21% above current price. The 200-day Moving Averages for DRNA is 6.57. It is -38.71% below current price. The 52-week High is 15.0. It is 39.93% from the current price. The 52-week Low is 2.52. It is -76.49% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 1.25 on 2018-02-28. Short % to float is 0.97%. There are some statistics of DRNA. It is has market cap $554.94 million. The share outstanding is 51.77 million. The average volume is 423211. The revenue is 859000. The percent of top 15 Institution holding is 61.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -108.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -89.37%.


Tags:

Share this post